Definitive Contract 75A50121C00089
Award Date
9/30/21
Potential Completion Date
2/29/24
Potential Value
$733K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Morrisville, NC, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
200
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, awarded a $12,606,489.57 Firm Fixed Price contract to AD Astra Diagnostics, Inc. for research and development of a CLIA-waived ubiquitous early sepsis detection system for use in ambulance, pre-hospital, and post-discharge settings. The contract has a period of performance through December 15, 2027 and was awarded on September 22, 2024. There was no set-aside...
Aidar Health, Inc. Rapid Advantage Division has been awarded a definitive firm fixed price contract valued at $336,128 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The contract aims to develop a multisensor-based machine learning technology for real-time automated detection of COVID-19 decompensation, with key deliverables due during the base period of performance through January 2024. Leveraging its proprietary devices and...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Accelerate Diagnostics, Inc., a for-profit manufacturer of in vitro diagnostic products and services for clinical microbiology laboratories. The contract, valued at $461,094.00, is to provide the VA with Accelerate Diagnostics' Accelerate Pheno system, which enables faster identification of pathogens and determination of appropriate antibiotic treatments. This technology supports prompt diagnosis...
This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Inflammatix, Inc., a small disadvantaged business. The $749,999 firm fixed-price contract supports research and development for the Triverity cartridge, a diagnostic tool focused on infection severity and sepsis detection, under Area of Interest #2 of ASPR's Easy Broad Agency Announcement. The...
This is a definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Inflammatix, Inc., a self-certified small disadvantaged business. The contract is for the development of the HOSTDX-Sepsis diagnostic test, a rapid point-of-care test that analyzes the host immune response to detect and classify sepsis. The contract has a firm fixed price of $510,000.00 and a completion date of November 30, 2021....
<p>The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a Firm Fixed Price contract worth $749,000.00 to In Diagnostics, Inc. to develop endpoint and kinetic measurement capabilities on a low-cost, disposable spectrophotometer platform. The contract has an ultimate completion date of June 30, 2025. This award was not set aside for any small business designation.</p>
This contract was awarded by the Defense Advanced Research Projects Agency (DARPA) to Inflammatix, Inc., a small disadvantaged business, for the development of a host-response prognostic tool called HOSTDXTM-COVID SEVERITY. The $453,851.00 contract is for research, development, and testing services related to diagnostic solutions for COVID-19 and other viral pandemics. Inflammatix has received over $29 million in federal contracts and grants from the Department of Health and Human Services to...
This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD) for the delivery of reagent kits. The contract has a ceiling value of $5,042.00 and an ultimate completion date of December 21, 2015. ACD is a molecular diagnostics company specializing in RNA detection technologies, and its proprietary RNAscope technology has been utilized in...
Advanced Cell Diagnostics, Inc. has been awarded an $11,183.20 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide RNAscope assay biological products including kits, reagents and probes. As a leader in molecular pathology, Advanced Cell Diagnostics will supply its proprietary RNAScope platform and accompanying products to support the federal research programs of the Department of Health and Human Services...
This is a $575,850.00 fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the In Vitro Antimicrobial Assessments 2011-2018 indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract was awarded to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute located in Seattle, Washington. The contract is for unspecified "OTHER FUNCTIONS" and does not have a set-aside designation. As a prime...